Nebenwirkungen · Glyxambi
Glyxambi 10 mg/5 mg film-coated tablets Glyxambi 25 mg/5 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 12
HOS-132007 · Präparat HOS-097168
In clinical trials with empagliflozin, the overall frequency of volume depletion (including the predefined terms blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolaemia, orthostatic hypotension, and syncope) was similar in patients treated with empagliflozin (empagliflozin 10 mg: 0.6%, empagliflozin 25 mg: 0.4%) and placebo (0.3%). The frequency of volume depletion events was increased in patients 75 years and older treated with empagliflozin 10 mg (2.3%) or empagliflozin 25 mg (4.3%) compared to placebo (2.1%).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-30T15:38:00Z · SHA-256 d1b6c02aa2f12210f2df98eee3125db78e248375ed7bdde02ef26597b2542dac · Passage e1718a37dd52bf377f8171ab33681c407767fc9ecf6ec2707c8b555327e73fba · Zeichen 12262–12836 im Abschnitt